Checkpoint Therapeutics Announces $20.0 Million Bought Deal Offering

NEXT STORY
Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab for the Treatment of Soft Tissue Sarcoma
PREV STORY
Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

author_avatar
NASDAQ Market News

Oasmia postpones the release of the Q4 and year-end report to 28 June

author_avatar
NASDAQ Market News

Mersana Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Updates

author_avatar
NASDAQ Market News